972 related articles for article (PubMed ID: 17402517)
61. [Hemoglobin sickle cell disease: experience of the Yalgado Ouedraogo University Hospital of Ouagadougou, Burkina Faso].
Ayéroué J; Kafando E; Kam L; Gué E; Vertongen F; Ferster A; Cotton F; Gulbis B
Arch Pediatr; 2009 Apr; 16(4):316-21. PubMed ID: 19261452
[TBL] [Abstract][Full Text] [Related]
62. Significant bronchospasm during sickle cell painful crises is associated with a lower peripheral eosinophil count.
Hassan H; Mughal I; Dar J; Al Mekki TE; Chapunduka Z; Haddad A; Hassan IS
Respirology; 2006 Sep; 11(5):633-7. PubMed ID: 16916338
[TBL] [Abstract][Full Text] [Related]
63. [Management of pain of acute sickle cell pain crises by health care providers in Mali].
Diallo DA; Baby M; Boiré A; Diallo YL
Med Trop (Mars); 2008 Oct; 68(5):502-6. PubMed ID: 19068984
[TBL] [Abstract][Full Text] [Related]
64. Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis.
Ahmed S; Siddiqui AK; Sison CP; Shahid RK; Mattana J
Eur J Haematol; 2005 Apr; 74(4):309-14. PubMed ID: 15777343
[TBL] [Abstract][Full Text] [Related]
65. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
[TBL] [Abstract][Full Text] [Related]
66. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
[TBL] [Abstract][Full Text] [Related]
67. The painful crisis of homozygous sickle cell disease. A study of the risk factors.
Baum KF; Dunn DT; Maude GH; Serjeant GR
Arch Intern Med; 1987 Jul; 147(7):1231-4. PubMed ID: 3606281
[TBL] [Abstract][Full Text] [Related]
68. [Sickle cell disease pain management following the World Health Organization's protocol].
Moussavou A; Vierin Y; Eloundou-Orima C; Mboussou M; Keita M
Arch Pediatr; 2004 Sep; 11(9):1041-5. PubMed ID: 15350992
[TBL] [Abstract][Full Text] [Related]
69. Fibrinolytic activity in adult Kenyan patients with sickle cell disease.
Aluoch JR
East Afr Med J; 1998 Jun; 75(6):351-2. PubMed ID: 9803619
[TBL] [Abstract][Full Text] [Related]
70. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.
Raphael JL; Mei M; Mueller BU; Giordano T
Pediatr Blood Cancer; 2012 Apr; 58(4):584-90. PubMed ID: 21584938
[TBL] [Abstract][Full Text] [Related]
71. Laparoscopic cholecystectomy in adult patients with sickle cell disease.
Vecchio R; Cacciola E; Murabito P; Gambelunghe AV; Murabito R; Cacciola RR; Di Martino M
G Chir; 2001; 22(1-2):45-8. PubMed ID: 11272437
[TBL] [Abstract][Full Text] [Related]
72. Influence of crisis on haemoglobin F level in adult Nigerian sickle cell anaemia patients.
Olatunji PO; Falusi AG; Esien EM
Cent Afr J Med; 1992 Jun; 38(6):242-6. PubMed ID: 1382859
[TBL] [Abstract][Full Text] [Related]
73. Management of acute painful crises in sickle cell disease.
Kotila TR
Clin Lab Haematol; 2005 Aug; 27(4):221-3. PubMed ID: 16048488
[TBL] [Abstract][Full Text] [Related]
74. [Sickle cell disease in childhood in 2004].
Girot R; Bégué P
Bull Acad Natl Med; 2004; 188(3):491-505; discussion 505-6. PubMed ID: 15584658
[TBL] [Abstract][Full Text] [Related]
75. [Management of acute complications in sickle cell disease ].
Gellen-Dautremer J; Brousse V; Arlet JB
Rev Prat; 2014 Oct; 64(8):1114-9. PubMed ID: 25510139
[TBL] [Abstract][Full Text] [Related]
76. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
77. Hospitalisations for sickle-cell disease in an Australian paediatric population.
Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
[TBL] [Abstract][Full Text] [Related]
78. [Acute complications in sickle cell disease].
Habibi A; Bachir D; Godeau B
Rev Prat; 2004 Sep; 54(14):1548-56. PubMed ID: 15558964
[TBL] [Abstract][Full Text] [Related]
79. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
[TBL] [Abstract][Full Text] [Related]
80. Day hospital versus inpatient management: An economic initiative of a pediatric center, examplified on uncomplicated vaso-occlusive crises of children with sickle cell disease.
Imbach P
Pediatr Blood Cancer; 2008 Sep; 51(3):317. PubMed ID: 18383149
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
